At ASMS 2023, SCIEX launches the Intabio ZT system, the first fully-integrated microfluidic chip-based platform combining imaged capillary isoelectric focusing separation and UV detection.

At ASMS 2023, SCIEX, launches the Intabio ZT system, the first fully-integrated microfluidic chip-based platform combining imaged capillary isoelectric focusing (icIEF) separation and UV detection.

Streamlined analysis of 40 PFAS compounds in wastewater and soil.

Agilent Technologies Inc. today announced two new liquid chromatography mass spectrometry systems (LCMS), the Agilent 6495D LC/TQ and the Agilent Revident LC/Q-TOF.

Thermo Fisher Scientific Inc. (NYSE: TMO), unveiled the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer.

Expert Intelligence (EI) announced at the 2023 ASMS conference in Houston, Texas its AI application builder for Mass Spectrometry analysis.

Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.

TriLink’s construction of the new 32,000-square-foot, cGMP-grade facility solidifies its commitment to advancing the field as more mRNA-based therapeutics and vaccines enter later-stage clinical trials.

Belong.Life has announced that the American Society of Clinical Oncology has published two abstracts in its 2023 Annual Meeting Abstract Book based on data aggregated from the Belong Beating Cancer Together app.

Personalis, Inc. has announced it will present new clinical data as scientific posters at the American Society of Clinical Oncology Annual Meeting 2023, which convenes from June 2-6, 2023, in Chicago, Ill.